Flt-1/Fc Chimera, Human, Recombinant <VEGF Receptor 1>

データシート

• 商品コード：321-FL-050
• メーカー：RSD
• 包装：50μg
• 価格： ¥77,000
• 在庫：1個

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Arap W et al. Steps toward mapping the human vasculature by phage display. Nat. Med. 2002 Feb;8(2):121-7
  Arap W et al
  2002/01/01
  
• 備考：
  Application: Binding Assay, Sample Type: Buffer - see notes
• 参照：
  

• No.： 2
• 文献情報：
  Argraves WS et al. VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels. Dev. Dyn. 2002 Nov;225(3):298-304
  Argraves WS et al
  2002/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Tissue
• 参照：
  

• No.： 3
• 文献情報：
  Maynard SE et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 2003 Mar;111(5):649-58
  Maynard SE et al
  2003/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 4
• 文献情報：
  Orecchia A et al. Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin. J. Cell. Sci. 2003 Sep;116(Pt 17):3479-89
  Orecchia A et al
  2003/01/01
  
• 備考：
  Species: Human, Application: Bioassay, Sample type: Whole Cells
• 参照：
  

• No.： 5
• 文献情報：
  Caine GJ et al. Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1. Eur. J. Clin. Invest. 2003 Oct;33(10):883-90
  Caine GJ et al
  2003/01/01
  
• 備考：
  Application: ELISA Standard, Sample Type: Plasma (Citrate)
• 参照：
  

• No.： 6
• 文献情報：
  Kodama I et al. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice. J. Bone Miner. Res. 2004 Feb;19(2):200-6
  Kodama I et al
  2004/01/01
  
• 備考：
  Application: In Vivo
• 参照：
  

• No.： 7
• 文献情報：
  Seo KH et al. Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. Cancer Res. 2004 Sep;64(18):6482-8
  Seo KH et al
  2004/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 8
• 文献情報：
  Xu F et al. Intraovarian actions of anti-angiogenic agents disrupt periovulatory events during the menstrual cycle in monkeys. Contraception 2005 Apr;71(4):239-48
  Xu F et al
  2005/01/01
  
• 備考：
  Application: In Vivo, Sample Type: Serum
• 参照：
  

• No.： 9
• 文献情報：
  Narazaki M et al. Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood 2006 May;107(10):3892-901
  Narazaki M et al
  2006/01/01
  
• 備考：
  Application: ELISA Standard, Sample Type: Whole Cells
• 参照：
  

• No.： 10
• 文献情報：
  Ozawa T et al. Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation. J. Mol. Cell. Cardiol. 2006 May;40(5):629-38
  Ozawa T et al
  2006/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 11
• 文献情報：
  Red-Horse K et al. Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation. J. Clin. Invest. 2006 Oct;116(10):2643-52
  Red-Horse K et al
  2006/01/01
  
• 備考：
  Species: Human, Application: Bioassay, Sample type: Whole Cells
• 参照：
  

• No.： 12
• 文献情報：
  Wei J et al. Human blood late outgrowth endothelial cells for gene therapy of cancer: determinants of efficacy. Gene Ther. 2007 Feb;14(4):344-56
  Wei J et al
  2007/01/01
  
• 備考：
  Species: Human, Application: Bioassay, Sample type: Whole Cells
• 参照：
  

• No.： 13
• 文献情報：
  Lake AC et al. Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1. J. Biol. Chem. 2006 Dec;281(49):37844-52
  Lake AC et al
  2006/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Buffer
• 参照：
  

• No.： 14
• 文献情報：
  McColl BK et al. Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2. FASEB J. 2007 Apr;21(4):1088-98
  McColl BK et al
  2007/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 15
• 文献情報：
  Taylor AP et al. Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts. Mol. Cancer Ther. 2007 Feb;6(2):524-31
  Taylor AP et al
  2007/01/01
  
• 備考：
  Species: Human, Application: Bioassay, Sample type: Whole Cells
• 参照：
  

• No.： 16
• 文献情報：
  Nishijima K et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am. J. Pathol. 2007 Jul;171(1):53-67
  Nishijima K et al
  2007/01/01
  
• 備考：
  Species: Rat, Application: In Vivo, Sample type: Whole Tissue
• 参照：
  

• No.： 17
• 文献情報：
  Krilleke D et al. Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. J. Biol. Chem. 2007 Sep;282(38):28045-56
  Krilleke D et al
  2007/01/01
  
• 備考：
  Application: Competitive Binding Assay
• 参照：
  

• No.： 18
• 文献情報：
  Gustafsdottir SM et al. Use of proximity ligation to screen for inhibitors of interactions between vascular endothelial growth factor A and its receptors. Clin. Chem. 2008 Jul;54(7):1218-25
  Gustafsdottir SM et al
  2008/01/01
  
• 備考：
  Application: Bioassay
• 参照：
  

• No.： 19
• 文献情報：
  Ponticelli S et al. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J. Biol. Chem. 2008 Dec;283(49):34250-9
  Ponticelli S et al
  2008/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Other: Tetrameric 4-23-5 Peptide
• 参照：
  

• No.： 20
• 文献情報：
  Rennel ES et al. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. Br. J. Cancer 2009 Oct;101(7):1183-93
  Rennel ES et al
  2009/01/01
  
• 備考：
  Application: Bioassay, Sample Type: protein in buffer
• 参照：
  

• No.： 21
• 文献情報：
  Kishuku M et al. Expression of soluble vascular endothelial growth factor receptor-1 in human monocyte-derived mature dendritic cells contributes to their antiangiogenic property. J. Immunol. 2009 Dec;183(12):8176-85
  Kishuku M et al
  2009/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 22
• 文献情報：
  Brookes K et al. Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs. Br. J. Cancer 2010 May;102(10):1524-32
  Brookes K et al
  2010/01/01
  
• 備考：
  Application: Other: See notes, Sample Type: Plasma (EDTA)
• 参照：
  

• No.： 23
• 文献情報：
  Lorquet S et al. Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment. FASEB J. 2010 Oct;24(10):3782-95
  Lorquet S et al
  2010/01/01
  
• 備考：
  Application: Bioassay,IHC Fresh, Sample Type: Whole Cells
• 参照：
  

• No.： 24
• 文献情報：
  Nishiguchi KM et al. Regulation of pathologic retinal angiogenesis in mice and inhibition of VEGF-VEGFR2 binding by soluble heparan sulfate. PLoS ONE 2010;5(10):e13493
  Nishiguchi KM et al
  2010/01/01
  
• 備考：
  Application: Bioassay, Sample Type: ocular fluid
• 参照：
  

• No.： 25
• 文献情報：
  Goyal A et al. Endorepellin, the angiostatic module of perlecan, interacts with both the ?2?1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism. J. Biol. Chem. 2011 Jul;286(29):25947-62
  Goyal A et al
  2011/01/01
  
• 備考：
  Application: Binding Competition, Sample Type: recombinant VEGFA and Endorepellin
• 参照：
  

• No.： 26
• 文献情報：
  Franco M et al. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. Blood 2011 Sep;118(10):2906-17
  Franco M et al
  2011/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 27
• 文献情報：
  Schreurs MP et al. The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy. FASEB J. 2012 Jan;26(1):355-62
  Schreurs MP et al
  2012/01/01
  
• 備考：
  Application: In Vivo, Sample Type: In Vivo
• 参照：
  

• No.： 28
• 文献情報：
  Tabata T et al. Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular remodeling in an in vivo human placentation model. Am. J. Pathol. 2012 Nov;181(5):1540-59
  Tabata T et al
  2012/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 29
• 文献情報：
  Qi JH et al. Tissue inhibitor of metalloproteinases-3 peptides inhibit angiogenesis and choroidal neovascularization in mice. PLoS ONE 2013;8(3):e55667
  Qi JH et al
  2013/01/01
  
• 備考：
  Application: Competitive ELISA, Sample Type: protein
• 参照：
  

• No.： 30
• 文献情報：
  Maertens L et al. Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis. PLoS ONE 2014;9(9):e106976
  Maertens L et al
  2014/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 31
• 文献情報：
  Kuchroo P et al. Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway. Stem Cells Dev. 2015 Feb;24(4):437-50
  Kuchroo P et al
  2015/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 32
• 文献情報：
  Yi KW et al. Effects of sFlt-1 and alpha 2-macroglobulin on vascular endothelial growth factor-induced endothelin-1 upregulation in human microvascular endothelial cells. Placenta 2014 Jan;35(1):64-9
  Yi KW et al
  2014/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 33
• 文献情報：
  Teran M et al. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity. J. Biol. Chem. 2015 Jun;290(26):16451-62
  Teran M et al
  2015/01/01
  
• 備考：
  Application: Bioassay, Sample Type: protein
• 参照：
  

• No.： 34
• 文献情報：
  Orecchia A et al. Endothelial cell adhesion to soluble vascular endothelial growth factor receptor-1 triggers a cell dynamic and angiogenic phenotype. FASEB J. 2014 Feb;28(2):692-704
  Orecchia A et al
  2014/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 35
• 文献情報：
  Yu Z et al. Tumor-Derived Factors and Reduced p53 Promote Endothelial Cell Centrosome Over-Duplication. PLoS ONE 2016;11(12):e0168334
  Yu Z et al
  2016/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：